Institutional
Krensavage Asset Management, LLC
CIK 0001609251
$255,697
Reported AUM
20
Positions
Q1 2026
Period
2026-05-15
Filed
The Brief · Krensavage Asset Management, LLC · Q1 2026
AI · grounded in 13F
Krensavage Asset Management, LLC closed its position in AVDL for a reduction of $18,444. The fund also exited CAH and INDV (Indivior PLC), while establishing a new position in INDV (Indivior Pharmaceuticals Inc) worth $10,349. Additionally, the manager increased its stake in RARE by 161.22% and doubled its holding in BIIB.
Portfolio · Q1 2026
Top holdings
QoQ vs Q4 2025
| # | Stock | Issuer | Price | Day % | 1Y Gr. | 5Y Gr. | Value | % of book | Δ shares (QoQ) | Status |
|---|---|---|---|---|---|---|---|---|---|---|
| 1 | UTHR | UNITED THERAPEUTICS CORP | $549.87 | 0.40% | 68.76% | 202.24% | $50K | 19.55% | −7,000 | −7.7% |
| 2 | ENTA | ENANTA PHARMACEUTICALS INC | $11.19 | -0.80% | 49.20% | -73.51% | $36K | 14.16% | +99,748 | +3.6% |
| 3 | JAZZ | JAZZ PHARMACEUTICALS PLC | $238.57 | -0.62% | 114.68% | 40.73% | $32K | 12.41% | — | HELD |
| 4 | BMRN | BIOMARIN PHARMACEUTICAL INC | $56.77 | 0.53% | 0.21% | -26.01% | $30K | 11.59% | — | HELD |
| 5 | EXEL | EXELIXIS INC | $52.70 | 0.40% | 22.47% | 212.76% | $18K | 6.97% | −77,833 | −15.8% |
| 6 | SNY | SANOFI-ADR | $45.02 | 1.44% | -5.85% | 8.19% | $16K | 6.10% | — | HELD |
| 7 | SUPN | SUPERNUS PHARMACEUTICALS INC | $44.75 | 0.11% | 34.99% | 69.96% | $15K | 5.67% | −32,818 | −10.5% |
| 8 | INDV | INDIVIOR PHARMACEUTICALS INC | $37.62 | 0.44% | 167.34% | 224.27% | $10K | 4.05% | +339,532 | NEW |
| 9 | RARE | ULTRAGENYX PHARMACEUTICAL IN | $21.91 | -6.01% | -41.05% | -72.55% | $8K | 3.20% | +241,245 | +161.2% |
| 10 | VNDA | VANDA PHARMACEUTICALS INC | $6.11 | 1.26% | 34.81% | -62.72% | $8K | 3.19% | — | HELD |
| 11 | EMBC | EMBECTA CORP | $3.35 | -0.89% | -63.50% | -87.30% | $7K | 2.54% | +735,340 | NEW |
| 12 | GSK | GSK PLC-SPON ADR | $51.52 | 0.49% | 29.73% | 57.71% | $5K | 2.09% | — | HELD |
| 13 | BNTX | BIONTECH SE-ADR | $88.08 | -1.69% | -18.81% | -72.82% | $5K | 2.07% | −40,000 | −40.2% |
| 14 | ALKS | ALKERMES PLC | $42.80 | -1.34% | 34.97% | 65.44% | $4K | 1.49% | — | HELD |
| 15 | BIIB | BIOGEN INC | $195.34 | -0.57% | 46.73% | -40.21% | $4K | 1.43% | +10,000 | +100.0% |
| 16 | REGN | REGENERON PHARMACEUTICALS | $635.45 | 1.07% | 29.54% | 11.50% | $3K | 1.21% | — | HELD |
| 17 | ARDX | ARDELYX INC | $5.62 | 1.17% | 51.09% | 219.54% | $3K | 1.17% | +500,000 | NEW |
| 18 | INMD | INMODE LTD | $13.54 | -0.59% | -4.38% | -76.18% | $2K | 0.65% | +120,942 | NEW |
| 19 | EOLS | EVOLUS INC | $6.72 | 0.75% | -33.57% | -38.35% | $649 | 0.25% | +57,985 | +58.0% |
| 20 | ABT | ABBOTT LABORATORIES | $91.07 | 0.32% | -30.43% | -17.31% | $513 | 0.20% | +5,000 | NEW |
| 21 | AVDL | AVADEL PHARMACEUTICALS | — | — | — | — | — | — | −855,860 | EXITED |
| 22 | CAH | CARDINAL HEALTH INC | $205.71 | 1.97% | 34.46% | 285.46% | — | — | −73,745 | EXITED |
| 23 | INDV | INDIVIOR PLC | $37.62 | 0.44% | 167.34% | 224.27% | — | — | −339,532 | EXITED |
Source: SEC EDGAR · accession 0001609251-26-000004. 13F discloses long positions only — shorts, foreign equities, and options are excluded.